| Financial Year |
March 31 2023 |
| Monetary Funds |
278,607,213.55 |
| Held-for-trading Financial Assets |
10,003,636.72 |
| Notes Receivable |
41,217,361.44 |
| Accounts Receivable |
192,483,506.34 |
| Advances to Suppliers |
7,307,328.63 |
| Other Receivables |
1,977,409.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
475,048,158.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,994,721.96 |
| Total Current Assets |
1,063,291,961.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
48,082,435.29 |
| Investment Properties |
19,235,076.40 |
| Fixed Assetes |
195,344,270.09 |
| Under-construction Projects |
539,322,672.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,962,432.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,527,920.59 |
| Deferred Income Tax Assets |
19,546,624.75 |
| Other Non-Current Assets |
146,828,970.14 |
| Sub-Total of Non-Current Assets |
1,013,616,080.48 |
| Total Assets |
2,076,908,041.96 |
| Short-Term Loans |
200,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,207,035.77 |
| Accounts Payable |
167,681,035.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,258,247.44 |
| Taxes Payable |
7,135,473.20 |
| Interest Payable |
863,167.20 |
| Dividend Payable |
-- |
| Other payables |
3,178,448.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,754,561.75 |
| Other Current Liabilities |
32,188,081.89 |
| Sub-Total of Current Liabilities |
443,507,091.77 |
| Long-term Loans |
288,497,770.11 |
| Bonds Payable |
284,891,585.35 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,353,237.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
648,609,075.30 |
| Total Liabilities |
1,092,116,167.07 |
| Paid-In Capital(Or Share Stock) |
115,277,000.00 |
| Capital Surplus |
409,106,196.08 |
| Surplus Reserve |
9,861,298.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
301,343,180.66 |
| Minority Stockholder's Interest |
52,697,212.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
932,094,662.82 |
| Owner's Equity（Stockholder's Equity） |
984,791,874.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,076,908,041.96 |
